Publikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (22)

2023

  1. Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth

    Thorax, Vol. 78, Núm. 3, pp. 233-241

  2. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  3. Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma

    Pediatric Allergy and Immunology, Vol. 34, Núm. 2

  4. Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

    Biomedicines, Vol. 11, Núm. 3

  5. Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 799-806.e6

  6. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

    European Journal of Pharmaceutical Sciences, Vol. 181

  7. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 3, pp. 706-715

2022

  1. Development of Lung Function in Preterm Infants During the First Two Years of Life

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 237-245

  2. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

2021

  1. A system pharmacology multi-omics approach toward uncontrolled pediatric asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  2. Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use

    European Respiratory Journal, Vol. 57, Núm. 5

2020

  1. Precision medicine in childhood asthma: Omic studies of treatment response

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

  2. Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infants

    Pediatric Allergy and Immunology, Vol. 31, Núm. 2, pp. 124-132

  3. The genomics and metagenomics of asthma severity (GEMAS) study: Rationale and design

    Journal of Personalized Medicine, Vol. 10, Núm. 3, pp. 1-16

2019

  1. Isolated pulmonary interstitial glycogenosis associated with alveolar growth abnormalities: A long-term follow-up study

    Pediatric Pulmonology, Vol. 54, Núm. 6, pp. 837-846

  2. Small Airway Dysfunction in Children With Controlled Asthma

    Archivos de Bronconeumologia, Vol. 55, Núm. 4, pp. 208-213

  3. Small Airway Dysfunction in Children With Controlled Asthma

    Archivos de Bronconeumologia

2015

  1. Patrones inflamatorios en niños asmáticos basados en la determinación de óxido nítrico alveolar

    Archivos de Bronconeumologia, Vol. 51, Núm. 6, pp. 279-284

  2. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life

    Pediatric Allergy and Immunology, Vol. 26, Núm. 8, pp. 797-804

  3. Validation of a Spanish version of the childhood asthma control test (Sc-ACT) for use in Spain

    Anales de Pediatria, Vol. 83, Núm. 2, pp. 94-103